NewAmsterdam Share Price
NASDAQ: NAMSW | Small Cap | Healthcare$8.82
+$8.82 (--%) Last updated on 16 Oct, 2026 | 20:07 ISTNewAmsterdam Stock Performance
NewAmsterdam Share Price Chart
$0.00$0.00
L
H
NewAmsterdam Quarterly Profit & Loss
All figures in USD
NewAmsterdam Annual Profit & Loss
All figures in USD
NewAmsterdam Balance Sheet
All figures in USD Million
NewAmsterdam Cash Flow
Annually
All figures in USD Million
About NewAmsterdam
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
NewAmsterdam Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $8.82 | $8.82 | -41.74% |
Aug 2026 | $15.14 | $15.14 | -19.47% |
Jun 2026 | $18.80 | $18.80 | -25.46% |
May 2026 | $25.22 | $25.22 | +13.20% |
Apr 2026 | $20.35 | $22.28 | +22.42% |
Mar 2026 | $18.20 | $18.20 | -21.48% |
Feb 2026 | $23.18 | $23.18 | +5.03% |
Dec 2025 | $22.07 | $22.07 | -22.53% |
Nov 2025 | $27.50 | $28.49 | +9.58% |
Oct 2025 | $18.10 | $26.00 | +75.79% |
Sep 2025 | $15.24 | $14.79 | +13.33% |
Aug 2025 | $10.41 | $13.05 | +19.94% |